Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease

被引:15
|
作者
Essex, Morgan [1 ,2 ,3 ,4 ]
Rios Rodriguez, Valeria [5 ]
Rademacher, Judith [6 ,7 ]
Proft, Fabian [5 ]
Loeber, Ulrike [2 ,8 ]
Marko, Lajos [2 ,8 ]
Pleyer, Uwe [9 ]
Strowig, Till [10 ,11 ,12 ]
Marchand, Jeremy [13 ]
Kirwan, Jennifer A. [14 ,15 ]
Siegmund, Britta [5 ]
Forslund, Sofia K. [16 ,17 ,18 ]
Poddubnyy, Denis [6 ,19 ]
机构
[1] Expt & Clin Res Ctr ECRC, Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Charite Univ Med Berlin, Med Dept Gastroenterol Infectiol & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[6] Charite Univ Med Berlin, Med Dept Gastroenterol Infectiol & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[7] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany
[8] German Ctr Cardiovasc Res DZHK, Berlin, Germany
[9] Charite Univ Med Berlin, Dept Ophthalmol, Campus Virchow, Berlin, Germany
[10] Helmholtz Ctr Infect Res, Braunschweig, Germany
[11] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany
[12] Ctr Individualized Infect Med CiiM, Hannover, Germany
[13] Charite Univ Med Berlin, BIH Metabol Platform, Berlin, Germany
[14] Charite Univ Med Berlin, MDC & BIH Metabol Platform, Berlin, Germany
[15] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England
[16] Charite Univ Med Berlin, ECRC, MDC, Berlin, Germany
[17] DZHK, Berlin, Germany
[18] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany
[19] German Rheumatism Res Ctr DRFZ, Berlin, Germany
关键词
INFLAMMATORY-BOWEL-DISEASE; DYSBIOSIS; IMPACT; SHAPE; BACTEROIDES; BIOMARKERS; PREVOTELLA; ARTHRITIS; BACTERIA; COLITIS;
D O I
10.1002/art.42658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Spondyloarthritis (SpA) is a group of immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders, such as acute anterior uveitis (AAU) and Crohn's disease (CD). The gut microbiome represents a promising avenue to elucidate shared and distinct underlying pathophysiology.Methods. We performed 16S ribosomal RNA sequencing on stool samples of 277 patients (72 CD, 103 AAU, and 102 SpA) included in the German Spondyloarthritis Inception Cohort and 62 back pain controls without any inflammatory disorder. Discriminatory statistical methods were used to disentangle microbial disease signals from one another and a wide range of potential confounders. Patients were naive to or had not received treatment with biological disease-modifying antirheumatic drugs (DMARDs) for >3 months before enrollment, providing a better approximation of a true baseline disease signal.Results. We identified a shared, immune-mediated disease signal represented by low abundances of Lachnospiraceae taxa relative to controls, most notably Fusicatenibacter, which was most abundant in controls receiving nonsteroidal antiinflammatory drug monotherapy and implied to partially mediate higher serum C-reactive protein. Patients with SpA showed an enrichment of Collinsella, whereas human leukocyte antigen (HLA)-B27+ individuals displayed enriched Faecalibacterium. CD patients had higher abundances of a Ruminococcus taxon, and previous conventional/synthetic DMARD therapy was associated with increased Akkermansia.Conclusion. Our work supports the existence of a common gut dysbiosis in SpA and related inflammatory pathologies. We reveal shared and disease-specific microbial associations and suggest potential mediators of disease activity. Validation studies are needed to clarify the role of Fusicatenibacter in gut-joint inflammation, and metagenomic resolution is needed to understand the relationship between Faecalibacterium commensals and HLA-B27. image
引用
收藏
页码:48 / 58
页数:11
相关论文
共 50 条
  • [31] Altered gut microbiota correlated with inflammation markers in Crohn's disease patients
    Hu, Jun
    Cheng, Sijing
    Yao, Jiayin
    Lin, Xutao
    Li, Yichen
    Wang, Wenxia
    Weng, Jingrong
    Zou, Yifeng
    Zhu, Lixin
    Zhi, Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 88 - 89
  • [32] Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn's disease
    Chen, Liang
    Lu, Zhanjun
    Kang, Dengfeng
    Feng, Zhongsheng
    Li, Gengfeng
    Sun, Mingming
    Liu, Zhanju
    Wu, Wei
    Fang, Leilei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Diet and gut microbiota manipulation for the management of Crohn's disease and ulcerative colitis
    Svolos, Vaios
    Gkikas, Konstantinos
    Gerasimidis, Konstantinos
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2021, 80 (04) : 409 - 423
  • [34] Gut dysbiosis and paediatric Crohn's disease
    Brusaferro, Andrea
    Cavalli, Elena
    Farinelli, Edoardo
    Cozzali, Rita
    Principi, Nicola
    Esposito, Susanna
    JOURNAL OF INFECTION, 2019, 78 (01) : 1 - 7
  • [35] Association of Fungi and Archaea of the Gut Microbiota with Crohn's Disease in Pediatric Patients-Pilot Study
    Krawczyk, Agnieszka
    Salamon, Dominika
    Kowalska-Duplaga, Kinga
    Bogiel, Tomasz
    Gosiewski, Tomasz
    PATHOGENS, 2021, 10 (09):
  • [36] Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients
    Doherty, Matthew K.
    Ding, Tao
    Koumpouras, Charlie
    Telesco, Shannon E.
    Monast, Calixte
    Das, Anuk
    Brodmerkel, Carrie
    Schloss, Patrick D.
    MBIO, 2018, 9 (02):
  • [37] Gut microbiota and mesenteric adipose tissue interactions in shaping phenotypes and treatment strategies for Crohn's disease
    Hasnaoui, Anis
    Trigui, Racem
    Giuffrida, Mario
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (46) : 4969 - 4976
  • [38] Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn's disease
    Budzinski, Lisa
    Kang, Gi-Ung
    Riedel, Rene
    Sempert, Toni
    Lietz, Leonie
    Maier, Rene
    Buettner, Janine
    Bochow, Bettina
    Tordai, Marcell T.
    Shah, Aayushi
    Abbas, Amro
    Momtaz, Tanisha
    Krause, Jannike L.
    Kempkens, Robin
    Lehman, Katrin
    Heinz, Gitta A.
    Benken, Anne E.
    Bartsch, Stefanie
    Necke, Kathleen
    Hoffmann, Ute
    Mashreghi, Mir-Farzin
    Biesen, Robert
    Kallinich, Tilmann
    Alexander, Tobias
    Jessen, Bosse
    Weidinger, Carl
    Siegmund, Britta
    Radbruch, Andreas
    Schirbel, Anja
    Moser, Benjamin
    Chang, Hyun-Dong
    GUT MICROBES, 2025, 17 (01)
  • [39] Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease
    He, Cong
    Wang, Huan
    Liao, Wang-Di
    Peng, Chao
    Shu, Xu
    Zhu, Xuan
    Zhu, Zhen-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (18) : 2204 - 2216
  • [40] The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn's Disease
    Starz, Eliza
    Wzorek, Karolina
    Folwarski, Marcin
    Kazmierczak-Siedlecka, Karolina
    Stachowska, Laura
    Przewlocka, Katarzyna
    Stachowska, Ewa
    Skonieczna-Zydecka, Karolina
    NUTRIENTS, 2021, 13 (07)